Company Filing History:
Years Active: 1996-1998
Title: Gail Ferstandig Arnold: Innovator in Chimeric Rhinoviruses
Introduction
Gail Ferstandig Arnold is a prominent inventor based in New Brunswick, NJ (US). She has made significant contributions to the field of immunology through her innovative work on chimeric rhinoviruses. With a total of 2 patents, her research has the potential to impact vaccine development and immunological applications.
Latest Patents
Arnold's latest patents focus on various novel recombinant chimeric human rhinoviruses. These include viruses that incorporate chimeric regions derived from influenza HA, poliovirus, and HIV-1 into human rhinovirus 14. The chimeric human rhinoviruses are particularly advantageous as they are only mildly pathogenic, possess numerous potential serotypes, and can elicit significant mucosal and serum immunological responses. The patents describe design considerations, methods, and examples of how these chimeric rhinoviruses can be utilized as vaccines and for various immunotechnological applications, including passive immunization, immunodiagnostic testing, and studies on antigenicity and immunogenicity.
Career Highlights
Gail Ferstandig Arnold is affiliated with Rutgers, the State University of New Jersey, where she continues her research and development in the field of immunology. Her work has garnered attention for its innovative approach to vaccine technology and immune response stimulation.
Collaborations
Arnold collaborates with Edward Arnold, contributing to the advancement of research in chimeric rhinoviruses and their applications in immunology.
Conclusion
Gail Ferstandig Arnold's contributions to the field of immunology through her patents on chimeric rhinoviruses highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for future vaccine development and immunological applications.